Association between the Hemoglobin Level and Cardiothoracic Ratio in Patients on Incident Dialysis

Takasuke Asakawa1, Nobuhiko Joki1, Yuri Tanaka1

  • 1Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan.

Cardiorenal Medicine
|March 5, 2015
PubMed

Insights

Lower hemoglobin (Hb) levels are linked to cardiac enlargement in end-stage kidney disease (ESKD) patients. Maintaining Hb above 9 g/dL may prevent heart remodeling before dialysis.

Area of Science:

  • Nephrology
  • Cardiology
  • Hematology

Background:

  • Cardiac remodeling is a concern in chronic kidney disease (CKD) patients.
  • End-stage kidney disease (ESKD) patients often experience cardiac enlargement.
  • Understanding factors contributing to cardiac remodeling is crucial for predialysis care.

Purpose of the Study:

  • To investigate the association between hemoglobin (Hb) levels and cardiac enlargement in ESKD patients.
  • To identify potential interventions for preventing cardiac remodeling in predialysis CKD.

Main Methods:

  • Cross-sectional study of 2,249 ESKD patients starting hemodialysis.
  • Examined Hb levels before the first hemodialysis session.
  • Assessed cardiothoracic ratios (CTRs) and clinical factors.

Main Results:

  • A negative linear correlation (r = -0.129, p < 0.001) was found between Hb levels and CTR.
  • Higher Hb levels were associated with decreased CTR and lower prevalence of CTR >50% (p < 0.001 for trend).
  • Hb levels <9 g/dL were significantly associated with CTRs >50%, even after adjusting for confounders.

Conclusions:

  • Lower Hb levels contribute to progressive cardiac enlargement in ESKD.
  • Maintaining Hb levels >9 g/dL may help prevent cardiac remodeling in predialysis CKD patients.
Abstract

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
737
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.0K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.7K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.7K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
610
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
323